Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection74

Select a period of time:

Views

Views
October 20252
November 20256
December 20254
January 20267
February 20260
March 20266
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Finland5
Brazil4
United Kingdom2
Ecuador2
Austria1
Kenya1
Mexico1
Paraguay1
 

Top cities views

Views
Helsinki5
Araruama1
Ashburn1
Asunción1
Cuenca1
Guayaquil1
Iztacalco1
Nairobi1
Piracicaba1
Rio de Janeiro1